Neumora Therapeutics, Inc. Common Stock Insider Transactions
Neumora Therapeutics, Inc. Common Stock Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 30,773 @ $10.80 | $332,348 | 3,694,916 | 09/25/2023 | 09/25/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 40,000 @ $11.14 | $445,600 | 3,664,143 | 09/22/2023 | 09/25/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 40,000 @ $11.14 | $445,600 | 3,664,143 | 09/22/2023 | 09/25/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 1,500,000 @ $17.00 | $25.50 M | 3,624,143 | 09/19/2023 | 09/20/2023 | |
ARCH Venture Partners X, LLC
10 percent owner |
Buy | 1,500,000 @ $17.00 | $25.50 M | 3,624,143 | 09/19/2023 | 09/20/2023 | |
Buy | 15,000 @ $12.62 | $189,371 | 15,000 | 09/19/2023 | 09/19/2023 |
Neumora Therapeutics, Inc. Common Stock FAQ's
The list of insiders at Neumora Therapeutics, Inc. Common Stock includes Lenz Robert A., Fust Matthew K.
Insiders have sold a total of 110,023 Neumora Therapeutics, Inc. Common Stock shares in the last 12 months for a total of 1.45 M sold.
The following insiders have sold Neumora Therapeutics, Inc. Common Stock shares in the last 12 months: Lenz Robert A. ($1.08 M), Fust Matthew K ($370,962),